By Ed Rabinowitz


Aggressive Goals Fuel Research, Growth at 'The James'

May 20th 2010

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute opened on July 9, 1990,as the adult patient-care component of The Ohio State University (OSU) Comprehensive Cancer Center (CCC).Today, "The James," as it is referred to, is the only dedicated cancer hospital in the Midwest.

Genomic Research Fuels Innovation at Johns Hopkins

May 19th 2010

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is one of only 40 cancer centers in the country designated by the National Cancer Institute as a Comprehensive Center. The physician researchers at the institution have been characterizing the acquired genome defects in cancers for the better part of the past few decades.

Radient Pharmaceuticals: New Name, New Focus

May 19th 2010

Executives at Radient Pharmaceuticals Corporation may one day look back on 2009 as the year when the coming-out party for the two-decades-old firm located in Tustin, California, began.

Pipeline and Collaborations Could Propel Seattle Genetics

May 19th 2010

If there is such a thing as a business trifecta, Seattle Genetics is nearly there. The Washington state biotechnology company is focused on the development and commercialization of monoclonal antibody–based therapies for the treatment of cancer and autoimmune disease. And with a potent pipeline of potential products and numerous technology and marketing collaborations in place, the opportunities for growth are in the air.

Will 2010 Be the Year that Ariad Closes the Gap?

May 19th 2010

When companies talk about "narrowing the gap," they typically mean closing the distance that separates them from their leading competitor. At Ariad Pharmaceuticals, however, that expression has taken on a new meaning: narrowing the distance from development to market for its two most promising compounds.

Tulane Cancer Center's Multifocal Mission: Teaching, Research, and Patient Care

May 18th 2010

In post-Katrina New Orleans, Louisiana, people refer to their return home and the revival of the city as �being back.� Today, the human spirit is thriving in the Big Easy�s resurrected communities and New Orleans is growing. The Tulane Cancer Center (TCC) at Tulane University Medical School has been the beneficiary of some of that growth.

Clarient Launches Pulmotype to Help Oncologists Choose the Right Therapy

May 18th 2010

In early February, Clarient Inc announced the commercial launch of its Insight Dx Pulmotype test that helps pathologists classify specific types of lung cancer so physicians can prescribe the most effective therapies.

The Shifting Landscape Toward Immunotherapies

May 17th 2010

Research and development in cancer has made a seismic shift toward immunotherapies, like anticancer vaccines, and the resulting tremor can be felt in the hallways and laboratories of drug and biotechnology companies large and small.

Extraordinary Care Is the Mission of the John Theurer Cancer Center

May 14th 2010

The John Theurer Cancer Center at Hackensack University Medical Center in New Jersey has been a leader in the diagnosis, treatment, management, and prevention of cancer for more than 30 years.

Is a Web Presence Worth the Effort?

January 20th 2009

Done right, the benefits of a practice portal extend beyond just dollars and cents.